GEAN — Genetic Analysis As Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Genetic Analysis As, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	24.2	46.8	25.3	16.3	13.4
Net Total Accounts Receivable
Net Total Receivables	1.93	8.42	8.36	11.2	7.57
Total Inventory
Total Other Current Assets
Total Current Assets	28	57.6	35.4	29.1	21.7
Net Property, Plant And Equipment	1.62	1.59	8.14	6.19	5.02
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	55.6	83.5	64.4	53.5	42.4
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.59	9.97	12.9	16	11.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9	11.4	20.3	21.5	19.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	46.6	72.1	44.1	32	22.5
Total Liabilities & Shareholders' Equity	55.6	83.5	64.4	53.5	42.4
Total Common Shares Outstanding